1. Home
  2. MYGN vs MBUU Comparison

MYGN vs MBUU Comparison

Compare MYGN & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$7.17

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Logo Malibu Boats Inc.

MBUU

Malibu Boats Inc.

HOLD

Current Price

$28.65

Market Cap

554.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
MBUU
Founded
1991
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
625.5M
554.5M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
MYGN
MBUU
Price
$7.17
$28.65
Analyst Decision
Hold
Hold
Analyst Count
13
8
Target Price
$12.58
$33.57
AVG Volume (30 Days)
1.1M
289.9K
Earning Date
11-03-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.98
Revenue
$825,300,000.00
$830,714,000.00
Revenue This Year
$0.10
N/A
Revenue Next Year
$5.28
$7.03
P/E Ratio
N/A
$29.04
Revenue Growth
0.21
11.54
52 Week Low
$3.76
$24.07
52 Week High
$16.63
$45.02

Technical Indicators

Market Signals
Indicator
MYGN
MBUU
Relative Strength Index (RSI) 47.96 53.69
Support Level $6.93 $27.04
Resistance Level $7.38 $28.98
Average True Range (ATR) 0.39 1.39
MACD 0.03 0.40
Stochastic Oscillator 39.88 87.99

Price Performance

Historical Comparison
MYGN
MBUU

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

About MBUU Malibu Boats Inc.

Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high end offshore and outboard motorboats in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.

Share on Social Networks: